NCT04893239View on ClinicalTrials.gov

Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 18, 2021

Primary Completion Date

February 23, 2022

Study Completion Date

February 23, 2022

Conditions
C. Diff. Infections
Interventions
BIOLOGICAL

LMN-201 Anti-toxin B VHH-1

Components of LMN-201

BIOLOGICAL

LMN-201 Anti-toxin B VHH-2

Components of LMN-201

BIOLOGICAL

LMN-201 Anti-toxin B VHH-3

Components of LMN-201

BIOLOGICAL

LMN-201 Anti-toxin B VHH-1, VHH-2, VHH-3

Components of LMN-201

Trial Locations (3)

4066

Wesley Medical Research Limited, Auchenflower

4558

Coastal Digestive Health, Maroochydore

4740

Coral Sea Clinical Research Institute, North Mackay

Sponsors
All Listed Sponsors
lead

Lumen Bioscience, Inc.

INDUSTRY